Introduction {#s1}
============

A long standing question in biological sciences is how cell diversity, specification patterns, and tissue complexity are generated during organ development. The mammalian brain is the most complex organ of any living organism. The question of how this enormous complexity is generated is still open. Such complexity is the result of millions of years of evolution that have equipped neural stem/progenitor cells (NSCs/NPCs) in the embryo with the ability to generate every neuron and glial cell in the brain via a combined action of extrinsic morphogenetic cues and intrinsic gene regulatory networks. For long time, it was thought that these networks are mainly based on cross-regulatory interactions between transcription factors (TFs) (Jessell, [@B24]; Politis et al., [@B47]; Kaltezioti et al., [@B26]; Martynoga et al., [@B37]; Stergiopoulos and Politis, [@B57]). However, the recent advent of sequencing methodologies and experimental data from large-scale consortia focused on characterizing functional genomic elements such as ENCODE and FANTOM, have revolutionized our view for organization, activity, and regulation of the mammalian genome (Carninci et al., [@B9]; Katayama et al., [@B31]; Birney et al., [@B7]). Surprisingly, the vast majority of the genome is transcribed producing not only protein-coding RNAs but also a vast number of different kinds of newly-identified classes of non-coding RNAs, including microRNAs (miRNAs-small non-coding RNAs) and long non-coding RNAs (lncRNAs). miRNAs have been extensively studied while the role of lncRNAs in cell biology together with novel roles of miRNAs in directly regulating lncRNAs have just begun to emerge (Amodio et al., [@B2],[@B3]; Rossi et al., [@B54]; Tay et al., [@B59]). LncRNAs are transcribed by RNA polymerase II, defined as endogenous cellular RNAs longer than 200 nt in length that lack an ORF, can be post-transcriptional processed by 5′ capping, polyadenylation, splicing, RNA editing, and exhibit specific sub-cellular localization (Qureshi and Mehler, [@B51]). Most importantly, it was recently shown that lncRNAs participate in the gene regulatory networks controlling embryonic stem cell (ESC) pluripotency and metastasis of cancer cells, as well as development and function of various tissues (Guttman et al., [@B18]; Gutschner and Diederichs, [@B16]; Qureshi and Mehler, [@B51]; Yang et al., [@B66]). Although lncRNAs are the most abundant classes of RNAs (Katayama et al., [@B31]; Birney et al., [@B7]; Kapranov et al., [@B30]; Kapranov and St Laurent, [@B28]), they remain poorly characterized and their roles in brain development have just begun to arise. Notably, it has been proposed that the number of lncRNAs far exceeds the number of protein-coding mRNAs in the mammalian transcriptome (Carninci et al., [@B9]; Kapranov et al., [@B29]) and the vast majority of them appears to be expressed in adult brain in a highly specific manner (Qureshi and Mehler, [@B51]).

In the last few years, many groups have focused their efforts toward understanding the actions of lncRNAs in brain function and evolution. In this mini-review, we highlight the emerging evidence of the involvement of this new class of RNA molecules in NSC biology during development and adulthood, in health and disease. In particular, we summarize recent progress regarding the participation of lncRNAs in the regulatory networks that control the fine balance between proliferation and differentiation decisions of NSCs. The ability of lncRNAs to interact with both genomic loci and protein products of TF genes appears to endow them with a remarkable capacity to control NSC maintenance and differentiation, suggesting an undoubtedly important influence on the pathophysiology of several neurodegenerative disorders (Kapranov et al., [@B27],[@B30]; Guttman et al., [@B17]; Khalil et al., [@B32]; Orom et al., [@B46]; Bian and Sun, [@B6]; Qureshi and Mehler, [@B51]; Spadaro and Bredy, [@B56]; Ng et al., [@B43]).

LncRNAs: new players in cell biology
====================================

LncRNAs can be classified as bidirectional, intronic, intergenic, sense, antisense or 3′-UTR (untranslated region) transcripts with respect to nearby protein-coding genes (Mercer et al., [@B38]; Derrien et al., [@B12]). Some lncRNAs are exported from nucleus and perform important functions in the cytoplasm, but more often they are found in nucleus, particularly associated with chromatin (Saxena and Carninci, [@B55]). In more detail, these transcripts may be bound by proteins, other RNA molecules or even fulfil intrinsic catalytic functions (Fedor and Williamson, [@B14]; Ye, [@B68]; Guttman and Rinn, [@B19]). The vast majority of these transcripts are not translated, supporting a role as non-coding RNAs rather than protein precursors (Banfai et al., [@B5]; Derrien et al., [@B12]). Furthermore, lncRNAs are developmentally regulated, expressed in specific cell types, associated with chromatin signatures indicating transcriptional regulation, are under evolutionary constraint and associated with carcinogenesis and other diseases; all of which support meaningful roles of lncRNAs (Qureshi and Mehler, [@B51]; Fatica and Bozzoni, [@B13]). LncRNAs also participate in a striking diversity of cellular processes including transcriptional regulation, genomic imprinting, alternative splicing, mRNA stability, translational control, DNA damage response, cell cycle regulation and organelle biogenesis (Rinn and Chang, [@B53]). Interestingly, it seems that knock-down or over-expression of many of these lncRNAs produce phenotypes that are very well correlated with their aberrant expression in disease states (Qureshi et al., [@B50]; Gutschner and Diederichs, [@B16]; Qureshi and Mehler, [@B51]). Therefore, we believe that lncRNA transcripts would eventually occupy a central place in our understanding of the molecular mechanisms underlying human diseases.

Systematical profiling and comprehensive annotation of lncRNAs in various cell types can shed light on the functionalities of these novel regulators. LncRNA-protein interactions can be currently predicted, approached and analyzed by various research advanced tools and strategies apart from bioinformatics, including high-throughput analysis of lncRNA expression \[microarrays, RNA sequencing \[RNA-Seq\] (Mortazavi et al., [@B41]; Wang et al., [@B64]; Ilott and Ponting, [@B21]), RNA CaptureSeq, iSeeRNA \[support vector machine (SVM)-based classifier\] (Sun et al., [@B58]), BRIC-Seq \[50-bromo-uridine (BrU) immunoprecipitation chase-deep sequencing analysis\] (Imamachi et al., [@B22])\], RIP \[RNA-binding protein (RBP) immunoprecipitation\] coupled with microarray and high-throughput sequencing (RIP-Chip/Seq respectively) (Zhao et al., [@B69]; Jain et al., [@B23]), ChIRP (chromatin isolation by RNA purification) and CHART (capture hybridization analysis of RNA targets---High-throughput finding of RBPs and DNAs) as well as CLIP (crosslinking-immunopurification)-Seq, which provides transcriptome-wide coverage for mapping RBP-binding sites (Khalil et al., [@B32]; Wu et al., [@B65]; Chu et al., [@B11]; Zhu et al., [@B70]).

LncRNAs in neural stem cells
============================

These technologies have greatly helped the efforts to elucidate the role of lncRNAs in NSCs, neural differentiation, migration and maturation. Toward this goal, Ramos and colleagues identified and predicted regulatory roles for more than 12,000 novel lncRNAs (2,265 lncRNAs had proximal protein-coding gene neighbors) in the subventricular zone (SVZ) of adult mice. In FACS-sorted NSCs, they found a unique lncRNA expression pattern for each of the three stages of neurogenesis analyzed. Moreover, by using ChIP-Seq (chromatin immunoprecipitation-sequencing), lncRNAs were shown to be transcriptionally regulated in a manner analogous to mRNAs, enabling the prediction of lncRNAs that may function in the glial-neuronal lineage specification of multipotent adult NSCs (Ramos et al., [@B52]; Wang et al., [@B62]). Further transcriptome-next-generation-sequencing revealed that lncRNA-mediated alternative splicing of cell fate determinants controls stem-cell commitment during neurogenesis. Specifically, Aprea and co-workers identified several genic and intergenic lncRNAs that are functionally involved in neurogenic commitment, including *Cosl1*, *Btg2-AS1*, *Gm17566*, *Miat* (Myocardial infarction associated transcript-*Gomafu*), *Rmst* (Rhabdomyosarcoma 2 associated transcript), *Gm17566*, *Gm14207*, *Gm16758*, *2610307P16Rik*, *AC102815.1*, *C230034O21Rik* and *9930014A18Rik* (Aprea et al., [@B4]). Accordingly, subsequent studies using high-throughput transcriptomic data (microarray platform) to examine lncRNA differential expression in NSCs, GABAergic neurons and oligodendrocytes, led to the identification of lncRNAs that are dynamically regulated during neural lineage specification, neuronal-glia fate switching and oligodendrocyte maturation \[i.e., *Dlx1AS* (Distal-less homeobox 1 antisense), *Evf2* (Embryonic ventral forebrain 2), *Rmst*, *utNgn1* (untranslated Neurogenin1), *MALAT1* (metastasis-associated lung adenocarcinoma transcript 1; also named *NEAT2*)\] (Mercer et al., [@B40]; Qureshi and Mehler, [@B51]; Ng et al., [@B43]). ChIP-Seq approaches were also developed to generate and investigate genome-wide chromatin-state maps. These functional analyses predicted hypothetical roles for 150 mammalian lincRNAs (long intergenic non-coding RNAs) in a "guilt-by-association" manner in NSCs. In particular, specific lincRNAs appeared to localize near genes encoding key TFs (such as *Sox2*, *Klf4*, *Myc*, *p53*, *NFkB* and *Brn1*) that are involved in processes ranging from hippocampal development to neuronal and oligodendrocyte maturation (Guttman et al., [@B17]; Qureshi and Mehler, [@B51]).

More concisely, Ramos et al. have also performed *in vitro* knock-down studies and observed that *Dlx1AS*, a lncRNA encoded from a bigene *Dlx1/2* cluster, is associated with fate determination of adult SVZ NSCs via positive regulation of *Dlx1* and *Dlx2* gene expression. Mechanistically, enhanced transcription of *Dlx1AS* occurs during neurogenesis when H3K27me3 (trimethylation of histone H3 Lys-27) repression is decreased. The H3K27me3-specific demethylase JMJD3 was also found to be enriched at the *Dlx1AS* locus (Figure [1A](#F1){ref-type="fig"}) (Gonzales-Roybal and Lim, [@B15]; Ramos et al., [@B52]). Recently, a comprehensive study came up with the finding that *UtNgn1* is a non-coding RNA transcribed from an enhancer region of the *Neurogenin1* (*Neurog1*) locus. This non-coding transcript seems to positively regulate *Neurog1* transcription during neuronal differentiation of NSCs. In detail, during the late stage of neocortical NSC development, *utNgn1* expression is up-regulated via involvement of Wnt signaling whereas it is down-regulated by PcG (polycomb group) proteins (Figure [1B](#F1){ref-type="fig"}) (Onoguchi et al., [@B45]). Additionally, two lncRNAs, nuclear enriched abundant transcripts *NEAT1* and *NEAT2* (*MALAT1*) are up-regulated in neuronal and glial progeny, and are associated with neuronal activity, growth and branching (Mercer et al., [@B40]; Ng et al., [@B43]). *Miat* (also called *Gomafu*) is one of the known non-coding RNAs that participates in neuronal subtype- specific determination and is also highly expressed in oligodendrocyte lineage specification (Aprea et al., [@B4]). In the same lineage, another lncRNA, *Nkx2.2AS*, an antisense RNA of the known homeobox TF *Nkx2.2*, appears to lead NSCs into oligodendrocytic fate through modest induction of *Nkx2.2* gene. By using deletion mutants, Tochitani and Hayashizaki showed that the overlapping regions of *Nkx2.2AS* and *Nkx2.2* isoforms are required for promoting *Nkx2.2* mRNA levels and the subsequent oligodendrocytic differentiation of NSCs (Figure [1C](#F1){ref-type="fig"}) (Tochitani and Hayashizaki, [@B60]). *Evf2* is predominantly detected in the developing forebrain, both in human and mouse, and is critical for GABAergic-interneuron formation. Like other lncRNAs, *Evf2* seems to control the expression of specific genes that are necessary during brain development, such as *Dlx5*, *Dlx6* and *Gad1*, through distinct *trans*- and *cis*-acting mechanisms (Figure [1D](#F1){ref-type="fig"}) (Bond et al., [@B8]). Interestingly, *Rmst* is presented to be a novel marker for dopaminergic neurons during NSC differentiation, where it is co-expressed with the midbrain-specific TF *Lmx1a* (Uhde et al., [@B61]).

![**Proposed schematic models for the role of different lncRNAs (green) in neural development. (A)** LncRNA *Dlx1AS* consists of two exons that are spliced and the mature transcript is polyadenylated. During neuronal differentiation of adult SVZ NSCs, *Dlx1AS* is required for the induction of *Dlx1* and *Dlx2* (red) gene expression (Gonzales-Roybal and Lim, [@B15]; Ramos et al., [@B52]). **(B)** During neocortical neurogenesis, *utNgn1* receive Wnt signals (i.e., Wnt3a) to induce the expression of *Neurog1* (red). PcG protein-mediated mechanisms (i.e., Ring1B, H3K27me3, H3K4me3, H3K9/K14ac) lead to the suppression of *utNgn1* (Onoguchi et al., [@B45]). **(C)** The overlapping regions of *Nkx2.2AS* and *Nkx2.2* isoforms (*I* and *II*-red) are necessary to promote *Nkx2.2* mRNA levels and the subsequent oligodendrocytic differentiation of NSCs (Tochitani and Hayashizaki, [@B60]). **(D)** Mechanistic pathway for *Evf2*-dependent interactions crucial for forebrain development. Secreted Shh (Sonic hedgehog) promotes expression of *Dlx1* and *Dlx2* (red), which sequentially suppress *Neuropilin2* and Notch signaling. Activation of *Evf2* leads to the formation of a regulatory network together with *Dlx*\'*s* (red) and *MECP2* (methyl CpG binding protein 2) that controls *GAD67* and GABAergic-interneuron formation (Bond et al., [@B8]). NSC, neural stem cell; *Evf1* (lncRNA) (blue), Embryonic ventral forebrain-1, Dlx6 antisense RNA 1 (*Dlx6AS1*).](fphys-05-00155-g0001){#F1}

Considering the tight connection between pluripotency of human ESCs and their differentiation into NSCs (ESC-derived NSCs) and subsequently into neurons, Ng and co-workers extensively showed that diverse lncRNAs are essential for ESC proliferation and neurogenesis through physical interaction with master TFs (e.g., *Sox2*). In detail, microarray data analysis led to the identification of 35 neuronal lncRNAs with important roles in neuronal differentiation, e.g., *Rmst* (*AK056164*, *AF429305* and *AF429306*), *lncRNA_N1* (*AK124684*), *lncRNA_N2* (*AK091713*), *lncRNA_N3* (*AK055040*, etc.). They also suggested that these lncRNAs are required for generation of neurons and suppression of gliogenesis by association with chromatin modifiers and nuclear proteins (Ng et al., [@B42]). In agreement, another study that aimed at identifying functional features of lncRNAs during ESC differentiation to adult cerebellum by utilizing RNA-Seq and ChIP-Seq technologies, demonstrated that filtered novel lncRNAs are located close to protein-coding genes involved in functions such as neuronal differentiation and transcriptional regulation (Guttman et al., [@B17]; Lv et al., [@B36]). Particular studies have been successful in identifying *anti-NOS2A* as an antisense transcript of the *NOS2A* (Nitric oxide synthase 2 enzyme) gene, an isoform of the NOS protein which induces hESC differentiation into neurogenic precursors (Korneev et al., [@B33]). Specific expression pattern was also detected for *Otx2c* (Orthodenticle homeobox 2 c), an alternative splicing variant of the pre-mRNA *Otx2* with a possible role in neural differentiation of hESCs (Liu et al., [@B35]). Another lncRNA that is correlated with the proliferation state of ESCs is *lincRNA-Sox2*, which is located at the promoter of *Sox2* locus and is regulated by *Sox2* and *Oct4* (Guttman et al., [@B17]). Finally, a thorough targeted RNA-Seq analysis carried out using neurons derived from patient-specific induced pluripotent stem cells (iPSCs) showed that more than 1,500 lncRNAs are dynamically regulated during differentiation of iPSCs toward glutamatergic neurons. Particularly, the expression of 1,622 non-coding genes (lncRNAs/lincRNAs) was dramatically affected during conversion from iPSCs to differentiating neurons, while alternative splicing occurred. Significant alterations were also observed in the expression patterns of non-coding genes involved in neuropsychiatric disorders (Lin et al., [@B34]; Qureshi and Mehler, [@B51]; Akula et al., [@B1]).

LncRNAs in brain function, evolution and neurological diseases
==============================================================

The importance of lncRNAs in the brain is explicitly highlighted by the observation that most of them are expressed in the adult mammalian brain in highly regional-, cellular- and sub-cellular compartment-specific and neuronal activity dependent profiles (Mercer et al., [@B39]; Ponjavic et al., [@B49]; Qureshi and Mehler, [@B51]). In fact, it seems that lncRNAs have played important roles in the evolution of the form and function of human brain, since the fastest evolving regions of the primate genome are non-coding sequences that generate lncRNAs implicated in the modulation of neuro-developmental genes (Pollard et al., [@B48]; Qureshi and Mehler, [@B51]). The most dramatic of these regions, called *HAR1* (human accelerated region 1), is part of a novel lncRNA gene (*HAR1F*) that is expressed specifically in Cajal--Retzius neurons in the developing human neocortex from 7 to 19 gestational weeks, a crucial period for cortical neuron-specification and migration. Additionally, analysis of highly conserved lncRNAs in birds, marsupials and eutherian mammals revealed a remarkable similarity in spatiotemporal expression profiles of orthologous lncRNAs, suggesting ancient roles during brain development (Chodroff et al., [@B10]). Moreover, lncRNAs directly modulate synaptic processes (*MALAT1*), protein synthesis (*BC1*), learning and memory (*Tsx*), and are associated with neuronal activity in mouse cortex (Qureshi and Mehler, [@B51]). In agreement with these effects on neurons, lncRNAs have also been implicated in the pathophysiology of neuro-developmental, neurodegenerative, neuro-immunological and neuro-oncological diseases/disorders. For instance, high levels of *BC1*/*BC200* and *BACE1-AS* have been implicated in Alzheimer\'s disease (AD) while *NEAT1*\'s in Huntington\'s disease (HD). *BC1*/*BC200* normally seems to selectively regulate local protein synthesis in post-synaptic dendritic compartments, by repressing translation via an *elF4*-*A*-dependent mechanism (Qureshi et al., [@B50]; Niland et al., [@B44]). De-regulation of *BACE1-AS* has been shown to be responsible for feed-forward induction of BACE1 (β-secretase); thus leading to amyloid β (Aβ) increased production and possible AD pathogenesis (Qureshi et al., [@B50]). Additionally, *NEAT1* is a lncRNA known to be involved in cell death mechanisms. In particular, *NEAT1* controls target gene transcription by protein sequestration into paraspeckles (stress-responsive sub-nuclear structures), a potentially dysfunctional pathway in HD progression. In accordance, Hirose and co-workers have very recently shown that *NEAT1* transcriptional up-regulation leads to the enlargement of these structures after proteasome inhibition (Johnson, [@B25]; Hirose et al., [@B20]). Various lncRNAs have also been correlated with Parkinson\'s disease (*PINK-AS1*, *UCHL1-AS1*), amyotrophic lateral sclerosis (*MSUR1*), Down\'s syndrome (*NRON*) as well as with tumor progression (*ANRIL*, *MALAT1*, *HOTAIR*, *NOS3AS*) (Gutschner and Diederichs, [@B16]). A common theme emerging from all these cases is that lncRNAs control the expression of nearby protein-coding genes *in cis* and de-regulation of this relationship could lead to nervous system-related diseases. In agreement, brain-expressed lncRNAs are preferentially located adjacent to protein-coding genes that are also expressed in the brain and involved in transcriptional regulation and/or nervous system development (Mercer et al., [@B39]; Ponjavic et al., [@B49]). Many of these pairs often exhibited coordinated expression during developmental transitions. Therefore, it was suggested that these lncRNAs may influence the expression of the associated protein-coding genes similarly to previously characterized examples such as *Nkx2.2AS*, *HOTAIR*, *p15AS*, *p21AS* and *Evf2*.

Perspective links between lncRNAs and brain development
=======================================================

Over recent years, it has become more and more evident that lncRNAs play key roles in gene regulatory networks controlling nervous system development. To initially investigate this link, we bioinformatically screened numerous mouse genes encoding TFs with well-established roles in CNS (central nervous system) development for close proximity with lncRNA genes (based on publicly available data from UCSC genome-browser). Accordingly, we managed to identify 79 such TF genes encompassing 91 transcriptional units for lncRNA genes in close proximity (\<3,000 base pairs-bp) (Table [1](#T1){ref-type="table"}). In particular, 40.65% of these lncRNAs are bidirectional, 16.48% intronic, 9.89% intergenic, 12.08% sense, 15.38% antisense and 5.49% 3′-UTR. The majority of these lncRNAs have only been identified in genome-wide expression screens, are expressed in nervous system, and intriguingly, their functions are totally unknown. Some of them have been reported to interact with TFs or chromatin-associated complexes (Wang and Chang, [@B63]; Guttman and Rinn, [@B19]; Rinn and Chang, [@B53]), indicating potential contribution to the combinatorial transcriptional codes involved in NSC maintenance, sub-type/lineage specification and terminal differentiation. Based on these preliminary evidence, we postulate that lncRNAs and TFs with regulatory role in neurogenesis are inter-connected and may form coherent cross-regulatory networks that are associated with CNS development. However, this hypothesis needs to be extensively interrogated in NSCs. Moreover, considering the fact that some TFs are used as reprogramming tools for the production of iPSCs, induced neurons, induced NSCs, cardiomyocytes, etc. (Yang et al., [@B67]), these lncRNAs may be utilized for the production of clinically useful cell types in the near feature, revolutionizing the basic principles of developmental/cell biology as well as neuroscience.

###### 

**List of genes encoding TFs with critical roles in brain development that also contain lncRNA genes in close proximity to their genomic loci (\<3,000 bp)**.

  **Genes encoding for TFs**   **LncRNAs**     **Position**
  ---------------------------- --------------- -----------------
  Ascl4                        AK018959        *Sense*
  Atoh7                        AK005214        *Sense*
  Crebbp                       4930455F16Rik   *Intergenic*
  Crx                          CrxOS           *Bidirectional*
  Ctnnb1                       4930593C16Rik   *Bidirectional*
  Cux2                         AK006762        *Sense*
  Cux2                         AK187608        *Bidirectional*
  Dlx1                         Dlx1AS          *Antisense*
  Dlx4                         A730090H04Rik   *Bidirectional*
  Dlx6                         Dlx6AS1         *Antisense*
  Dlx6                         Dlx6AS2         *Intronic*
  Emx2                         Emx2OS          *Bidirectional*
  Evx1                         5730457N03Rik   *Bidirectional*
  FezF1                        FezF1-AS1       *Bidirectional*
  FezF1                        AK086573        *Intergenic*
  FoxA2                        AK156045        *Antisense*
  FoxG1                        AK158887        *Intergenic*
  FoxG1                        3110039M20Rik   *Sense*
  Gata1                        S57880          *Sense*
  Gata2                        AK137172        *Sense*
  Gata3                        4930412013R     *Bidirectional*
  Gata4                        AK031341        *Intronic*
  Gata6                        AK033147        *Bidirectional*
  Gata6                        AK003136        *Bidirectional*
  Gbx2                         D130058E05Rik   *Bidirectional*
  Gli1                         AK157048        *Sense*
  Gli2                         AK054469        *Intronic*
  Gli3                         AK135998        *Intergenic*
  Hmx1                         E130018O15Rik   *Bidirectional*
  Irx2                         Gm20554         *Bidirectional*
  Lef1                         Lef1-AS1        *Bidirectional*
  Lhx1                         Lhx1OS          *Bidirectional*
  Lhx3                         AK035055        *Bidirectional*
  Lhx8                         AI606473        *Bidirectional*
  Lmx1b                        C130021I20      *Bidirectional*
  Lxrb (NR1H2)                 AK184603        *3 ′-UTR*
  Meis1                        AK144295        *Antisense*
  Meis2                        AK012325        *Sense*
  Meis2                        AK144367        *Bidirectional*
  Meis2                        AK144485        *Bidirectional*
  Msx1                         Msx1AS          *Antisense*
  MycN                         MYCNOS          *Bidirectional*
  Myt1L                        AK138505        *Antisense*
  NFATc1                       AK155068        *3 ′-UTR*
  NFATc4                       AK014164        *Sense*
  NFIA                         E130114P18Rik   *Bidirectional*
  NFIB                         AK081607        *Intronic*
  NFIx                         AK168184        *Antisense*
  NFkB2                        AK029443        *Bidirectional*
  Ngn1                         AK016084        *Intergenic*
  Nkx2.2                       Nkx2.2AS        *Antisense*
  Notch1                       AK075572        *Antisense*
  NR2F1                        AK051417        *Intergenic*
  NR2F1                        A830082K12Rik   *Bidirectional*
  NR2F2                        AK135306        *Intronic*
  NR3C2                        Gm10649         *Bidirectional*
  NR4A2                        BB557941        *Intergenic*
  NR5A2 (lrh-1)                AK178198        *Antisense*
  NR5A2 (lrh-1)                AK145521        *Intronic*
  Otx2                         Otx2OS          *Bidirectional*
  Pax2                         AK006641        *Antisense*
  Pax6                         AK044354        *Antisense*
  Pbx3                         AK138624        *Intronic*
  Pou4F1                       AK084042        *Intergenic*
  PPARd                        AK033897        *Intronic*
  PPARd                        AK007468        *Intronic*
  Prox1                        AK142161        *Bidirectional*
  Ptf1a                        AK053418        *Antisense*
  RARa                         AK031732        *Intronic*
  RARb                         AK052306        *3 ′-UTR*
  RBPjK                        AK164362        *Intronic*
  Runx1                        AK131747        *Intergenic*
  SATB2                        9130024F11Rik   *Bidirectional*
  Six1                         AK035085        *3 ′-UTR*
  Six3                         Six3OS1         *Bidirectional*
  Six6                         4930447C04Rik   *Bidirectional*
  Sox1                         Gm5607          *Sense*
  Sox10                        GM10863         *Bidirectional*
  Sox2                         Sox2OT          *Sense*
  Sox21                        AK039417        *Bidirectional*
  Sox8                         AK079380        *Bidirectional*
  Sox9                         BC006965        *Bidirectional*
  STAT5b                       AK088966        *Intronic*
  Tgif2                        5430405H02Rik   *3 ′-UTR*
  THRA                         AK165172        *Intronic*
  THRB                         AK088911        *Antisense*
  WT1                          AK033304        *Intronic*
  WT1                          AI314831        *Bidirectional*
  Zeb1                         AK041408        *Intronic*
  Zeb1                         Gm10125         *Bidirectional*
  Zeb2                         Zeb2OS          *Bidirectional*

Some of these TFs contain more than one lncRNA near to their genes (duplicates). The position of each lncRNA relatively to its nearby protein-coding gene is indicated at the third column of the table.

To further examine the links between lncRNAs, brain development and neurological disorders, we tested whether lncRNAs, associated with nervous system-related diseases in humans, are expressed in embryonic mouse brain (*E15.5*) or *ex vivo* cultured NSCs (isolated from mouse telencephalon, *E15.5*). The rational for these experiments was based on observations showing many neurological diseases to be initiated very early during brain maturation and development (Bian and Sun, [@B6]; Qureshi and Mehler, [@B51]). Specifically, we first identified *in silico* and then tested for expression 20 such lncRNAs with clear conservation in mouse genome. Interestingly, RT-PCR (reverse transcription-PCR) analysis revealed that most lncRNAs are expressed in both brain and NSCs (Figure [2](#F2){ref-type="fig"}), suggesting potential involvement in brain development. Moreover, a possible function of these lncRNAs in NSCs may contribute to their roles in neurological diseases. Nevertheless, further investigation and initiation of new experimental studies are needed to uncover the exact function of lncRNAs in NSCs and nervous system in general.

![**RT-PCR-based detection of various lncRNAs associated with CNS-related diseases or disorders**. Experiments were performed using cDNA samples derived from embryonic mouse brain (*E15.5*) or NSCs isolated from embryonic mouse telencephalon and cultured *ex vivo*, as indicated. In some cases alternative splicing isoforms are also evident. RT-PCR primer sequences are available upon request.](fphys-05-00155-g0002){#F2}

Conclusions {#s2}
===========

LncRNAs represent a new exciting frontier in molecular biology with major roles in NSC fate decisions, specification and commitment. Full understanding of how these non-coding transcripts regulate the expression of protein-coding genes and participate in gene regulatory circuitries could lead to the discovery of novel cellular/molecular mechanisms and signaling pathways involved in neural development; thus having potential implications for the treatment of nervous system-related diseases and traumas.
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